Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9113 USD | -0.95% | -0.96% | +3.67% |
Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | 6.94M | Sales 2023 | 8.01M | Capitalization | 5.25M |
---|---|---|---|---|---|
Net income 2022 | -21M | Net income 2023 | -5M | EV / Sales 2022 | -0.59 x |
Net cash position 2022 | 8.63M | Net cash position 2023 | 10.87M | EV / Sales 2023 | -0.7 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
-0.83
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.4% |
1 day | -0.95% | ||
1 week | -0.96% | ||
Current month | +0.12% | ||
1 month | -0.07% | ||
3 months | -7.95% | ||
6 months | -2.01% | ||
Current year | +3.67% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Nancy Seretta
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Aaron Fox-Collis
AUD | Comptroller/Controller/Auditor | - | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.9113 | -0.95% | 1,903 |
24-05-09 | 0.9201 | -2.01% | 7,285 |
24-05-08 | 0.939 | +4.32% | 32,757 |
24-05-07 | 0.9001 | -3.11% | 4,505 |
24-05-06 | 0.929 | +0.96% | 2,195 |
Delayed Quote OTC Markets, May 10, 2024 at 03:56 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.67% | 5.5M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- FRTX Stock